HR 8839 United States House · 118th Congress

Maternal and Infant Syphilis Prevention Act

This bill requires the federal government to issue guidance to state Medicaid programs within 12 months to improve syphilis screening for pregnant women and newborns. It specifically encourages states to expand third-trimester and delivery screenings, integrate telehealth services, provide multilingual education for providers and patients, and enhance treatment protocols. The guidance aims to prevent congenital syphilis - where syphilis is passed from mother to baby during pregnancy - which caused over 3,700 newborn cases in 2022. States must report on implementing these practices to Congress within two years. The bill directly affects pregnant women, newborns, and Medicaid providers by standardizing and improving access to critical syphilis prevention services.
Sub-Topics: Medicaid Telehealth
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2024
Committee Review
Floor Vote
President
Introduced Jun 26, 2024 Last action Jun 26, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Jun 26, 2024
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 26, 2024
Introduced
Introduced in House
lower
1 primary · 10 co-sponsors

Sponsors